A modernist reading. Nothing more.

§ 01 What this site is

BPC-157 Dr. is an independent research-summary publication. Its purpose is to make the published BPC-157 literature legible to a careful reader — researchers, clinicians who encounter questions from patients, journalists, athletes navigating WADA rules, and lay readers trying to understand what is actually known about a peptide that the open internet describes with varying levels of accuracy.

The publication is structured around six pages: an overview (this page is page five), a research summary indexed by tissue and mechanism, a dosage page that reports dose ranges in the species in which they were studied, a frequently-asked-questions page, a full reference list with DOIs, and a contact page.

The word Dr. in the domain reflects the publication's voice — a single editor's reading of the field, set in a clean grid, like a one-physician letterhead — not a clinical service of any kind.

§ 02 What this site is not

This site does not operate a clinic. It employs no clinicians. It does not prescribe medication, hand out any product, recommend doses, or refer readers to vendors. It is not affiliated with any pharmacy, supplement company, telehealth service, or peptide retailer. It is an editorial digest, not a storefront — nothing on it is offered for sale.

It does not provide medical advice. It does not provide a protocol. It does not extrapolate a 10 μg/kg dose in a rat to any human dose under any condition.

It is not a restoration of any previous owner of the domain. It is a new editorial publication at this address.

§ 03 Editorial standards

Every quantitative claim on the site cites a published study with DOI and PubMed/PMC URL. Dose values are reported in the species and route in which they were administered. Mechanisms are described as reported or studied rather than as established fact when the underlying evidence is preclinical and unreplicated.

Where the evidence base is thin, the site says so. The single most important fact on the site is that thirty-five of thirty-six BPC-157 articles in the 2025 HSS Journal systematic review were preclinical ^[16]. That ratio is repeated wherever a reader might mistake the breadth of the rodent record for clinical validation.

The site does not mention competitor product brand names. It does not link to vendors. It does not run trackers, pixels, or analytics. It does not collect personal data.

§ 04 Sources and citations

Primary sources are PubMed, PubMed Central, journal websites, and ClinicalTrials.gov. Regulatory positions are taken from FDA and WADA official documents. Reviews and systematic reviews are used to triangulate primary findings.

The full reference list appears on /references. Each citation links to the DOI or to the open-access PMC version when one is available.